A review of the scientific literature as it pertains to Gulf War illnesses, Depleted uranium.

Contributor(s):

Material type: Text

TextSeries: Gulf War illnesses series ; v. 7.Publication details: Santa Monica, Calif. : RAND, 1999.Description: 1 online resource (144 pages) : illustrations, mapsContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

0585344930
9780585344935
9780833026811
083302681X

Other title:

Depleted uranium

Subject(s):

Genre/Form:

Additional physical formats: Print version:: Review of the scientific literature as it pertains to Gulf War illnesses, Depleted uranium.DDC classification:

616.9/8023 21

LOC classification:

RB152.7 .R48 1998eb

Online resources:

Click here to access online

Summary: The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications. -- Provided by publisher.

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

"Prepared for the Office of the Secretary of Defense, National Defense Research Institute."

"MR-1018-OSD."

Includes bibliographical references.

The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications. -- Provided by publisher.